<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dacomo L</submitter><funding>Fondazione Cariplo</funding><pagination>e14263</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11464142</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(10)</volume><pubmed_abstract>Frailty is a geriatric, multi-dimensional syndrome that reflects multisystem physiological change and is a transversal measure of reduced resilience to negative events. It is characterized by weakness, frequent falls, cognitive decline, increased hospitalization and dead and represents a risk factor for the development of Alzheimer's disease (AD). The fact that frailty is recognized as a reversible condition encourages the identification of earlier biomarkers to timely predict and prevent its occurrence. SAMP8 (Senescence-Accelerated Mouse Prone-8) mice represent the most appropriate preclinical model to this aim and were used in this study to carry transcriptional and metabolic analyses in the brain and plasma, respectively, upon a characterization at cognitive, motor, structural, and neu</pubmed_abstract><journal>Aging cell</journal><pubmed_title>Transcriptomic and metabolomic changes might predict frailty in SAMP8 mice.</pubmed_title><pmcid>PMC11464142</pmcid><funding_grant_id>2017-0557</funding_grant_id><funding_grant_id>2017‐0557</funding_grant_id><pubmed_authors>Leva S</pubmed_authors><pubmed_authors>Gagliardi S</pubmed_authors><pubmed_authors>Brunelli L</pubmed_authors><pubmed_authors>La Vitola P</pubmed_authors><pubmed_authors>Artioli L</pubmed_authors><pubmed_authors>Cecutti G</pubmed_authors><pubmed_authors>Carelli S</pubmed_authors><pubmed_authors>Guaita A</pubmed_authors><pubmed_authors>Forloni G</pubmed_authors><pubmed_authors>Messa L</pubmed_authors><pubmed_authors>Pastorelli R</pubmed_authors><pubmed_authors>Micotti E</pubmed_authors><pubmed_authors>Sinopoli E</pubmed_authors><pubmed_authors>Pansarasa O</pubmed_authors><pubmed_authors>Dacomo L</pubmed_authors><pubmed_authors>Balducci C</pubmed_authors><pubmed_authors>Cereda C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Transcriptomic and metabolomic changes might predict frailty in SAMP8 mice.</name><description>Frailty is a geriatric, multi-dimensional syndrome that reflects multisystem physiological change and is a transversal measure of reduced resilience to negative events. It is characterized by weakness, frequent falls, cognitive decline, increased hospitalization and dead and represents a risk factor for the development of Alzheimer's disease (AD). The fact that frailty is recognized as a reversible condition encourages the identification of earlier biomarkers to timely predict and prevent its occurrence. SAMP8 (Senescence-Accelerated Mouse Prone-8) mice represent the most appropriate preclinical model to this aim and were used in this study to carry transcriptional and metabolic analyses in the brain and plasma, respectively, upon a characterization at cognitive, motor, structural, and neu</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2026-07-14T20:34:34.766Z</modification><creation>2025-04-06T16:25:25.911Z</creation></dates><accession>S-EPMC11464142</accession><cross_references><pubmed>38961613</pubmed><doi>10.1111/acel.14263</doi></cross_references></HashMap>